Regenerative Medicine Sector ARMs Itself With New Advocacy Group
This article was originally published in The Pink Sheet Daily
Executive Summary
Companies and researchers developing cell-based and tissue engineering therapies form a lobbying group to improve federal policies surrounding their efforts. The Alliance for Regenerative Medicine is ramping up to make itself heard in Washington.